LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Our findings expand the clinical and mutational spectrum of LCCS8, showing a possible correlation between the impact of the ADCY6 missense variants reported to date, predicted by molecular modelling, and the severity of the phenotype.This article is protected by copyright.All rights reserved.
|
31846058 |
2020 |
LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.
|
26257172 |
2015 |
LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.
|
24319099 |
2014 |
LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.
|
24319099 |
2014 |
LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
LETHAL CONGENITAL CONTRACTURE SYNDROME 8
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Other ureteric obstruction
|
0.200 |
Biomarker
|
phenotype |
RGD |
Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction.
|
18971210 |
2009 |
Arthrogryposis
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.
|
24319099 |
2014 |
Arthrogryposis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Oropharyngeal Dysphagia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory distress
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Facial diplegia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Limitation of joint mobility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Reduced tendon reflexes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diarrhea
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
We generated intestinal epithelial cell-specific adenylyl cyclase 6 (AC6) knockout mice to study its role in CT-induced diarrhea.
|
30624615 |
2019 |
Diarrhea
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Our finding that the CFTR-AC6 protein complex is the key mediator of CTX-associated diarrhea may facilitate development of antidiarrheal agents to manage cholera symptoms and improve outcomes.
|
29903911 |
2018 |
Anemia, Sickle Cell
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemia.
|
27067484 |
2016 |
Heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
AC6 gene transfer safely increased LV function beyond standard heart failure therapy, attainable with one-time administration.Larger trials are warranted.
|
27437887 |
2016 |
Anemia, Sickle Cell
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We postulate that ADRB2 and ADCY6 polymorphisms may influence SCD severity through the mechanism of RBC adhesion.
|
18324973 |
2008 |
Heart failure
|
0.020 |
Biomarker
|
disease |
LHGDN |
Adenylylcyclase gene transfer increases function of the failing heart.
|
17007567 |
2006 |
Alkalosis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
They uncovered a complex role of AC6, specifically affecting acid-base balance during HCO<sub>3</sub><sup>-</sup> load, which causes pronounced alkalosis in AC6-deficient mice.
|
30220652 |
2018 |